A landmark federal report released in 2017 outlined what’s known about the potential health benefits and risks of marijuana use.
Tag Archives: PTSD
The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.
Medical cannabis cards in the Mountain State won’t see the light of day until July 1, 2019, but it appears prospective patients might have an easier time finding a West Virginia medical cannabis doctor.
Patients in the state of New York suffering from post-traumatic stress disorder will now be able to use medical cannabis to treat PTSD.
NEW YORK, Nov. 11, 2017 /Weed Wire/ — Governor Andrew M. Cuomo today signed five pieces of legislation to further support New York veterans by improving healthcare and services, as well as memorialize veterans throughout New York State in a number of different ways.
A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.
DENVER, Oct. 26, 2017 /Weed Wire/ — Five years ago this November, Colorado citizens voted to pass Amendment 64, the legislative act which legalized adult-use marijuana in the Centennial State.
Medical cannabis may help children suffering from chemotherapy induced nausea as well as seizures, according to a new study published in the October edition of the medical journal Pediatrics.
MIAMI, Fla., Oct. 6, 2017 /Weed Wire/ — After transferring to the Miami VA Healthcare System and during a medical intake, the VA was adamant about Jonathan Fruchter being referred to drug counseling regardless of the fact that he is patient #P0032257 with the Compassionate Use Registry in the state of Florida.
TRENTON, N.J., Sept. 20, 2017 /Weed Wire/ — The only way the VA can learn about the multiple benefits of cannabis related to PTSD, and how medical cannabis can save lives, is by sitting down with the person who is actually allowed to consume it directly under the watchful eye of the Veterans Administration, Jonathan Fruchter.
From WEEDIQUETTE’s “Chronic Trauma” episode: Krishna accompanies rapper JohnboyCOOL to learn about medicinally treating his trauma with cannabis.
On Aug. 6, 2017, Sue Sisley, M.D., sent a letter to Secretary of Veterans Affairs David Shulkin to request that he stop a Phoenix hospital’s obstruction of the first clinical trial to study the effects of medical cannabis in the treatment of post-traumatic stress disorder in military veterans.
“Complex Live” gets to know Artizen — a Seattle-based cannabis company that employs over a dozen military veterans — and its employees, many of whom have used the plant to treat PTSD.
Even though pain and posttraumatic stress disorder (PTSD) are among the most common reasons people use medical marijuana in the U.S., there isn’t much proof cannabis works for either one of these conditions, two research reviews suggest.
NEW ORLEANS, Aug. 9, 2017 /Weed Wire/ — Dewmar International BMC, Inc. (the “Company”) (OTC PINK: DEWM) today announced that it has filed documents with the United States Patent and Trademark Office for the treatment of Post-Traumatic Stress Disorder (PTSD) using cannabinoids.
The Delaware medical marijuana program is making safe access easier for those who suffer from post-traumatic stress disorder. On July 13, 2017, Delaware Gov. John Carney signed Senate Bill 24, removing the original law’s requirement that PTSD patients be authorized specifically by a psychiatrist.
WILMINGTON, Del., July 13, 2017 /Weed Wire/ – Governor John Carney this week signed into law Senate Bill 24, which will expand access to medical marijuana treatment for Delaware veterans, and other Delawareans, suffering from post-traumatic stress disorder.
SAINT PAUL, Minn., July 6, 2017 /Weed Wire/ — As of July 1, Minnesota patients with post-traumatic stress disorder (PTSD) can register to receive medical cannabis through the state’s medical cannabis program.
While recreational legalization failed recently in the Green Mountain State, the Vermont medical marijuana program is still making progress.
The legislative session in Albany officially ended last week and medical marijuana advocacy groups are wondering where one of the laws that was passed stands.
Florida medical marijuana legislation has finally expanded the state’s medical marijuana program. On June 26, 2017, Florida Gov. Rick Scott signed into law SB 8-A, a bill that expands the state’s program by adding cultivators and qualifying conditions.
Post-traumatic stress disorder may become the next condition approved for the New York medical marijuana program after state lawmakers gave their approval on June 20, 2017.
ALBANY, NY, June 20, 2017 / — The New York State Senate on Tuesday passed legislation sponsored by Senator Diane Savino (D-SI/Brooklyn) to add Post Traumatic Stress Disorder to the list of qualifying conditions treatable with medical marijuana in New York State.
ALBANY, New York, June 20, 2017 /Weed Wire/ — A bipartisan proposal to add post-traumatic stress disorder (PTSD) as a qualifying condition for New York’s medical marijuana program has received final approval from state lawmakers and is headed to the desk of Gov. Andrew Cuomo.
On June 5, 2017, Colorado Gov. John Hickenlooper signed Senate Bill 17, approving post-traumatic stress disorder as a qualifying condition for the state’s medical marijuana program. With the addition of Colorado, there are now 20 states, plus Washington, D.C., that allow medical marijuana for PTSD.
DENVER, June 6, 2017 /Weed Wire/ – The Colorado General Assembly recently approved SB 17-17 to add Post-Traumatic Stress Bill to the list of approved medical conditions for the use of medical cannabis.
During a press briefing on May 31, 2017, Veterans Affairs Secretary David Shulkin fielded a reporter’s question regarding medical marijuana for veterans.
One of the largest veteran services organizations in the United States is making a push to change marijuana’s status as a Schedule I substance.
Concerns from a special interest group and a state agency torpedoed a bill that would expand access to Delaware’s medical marijuana program.
New Jersey might get an influx of new medical marijuana patients. On May 11, 2017, the New Jersey Medicinal Marijuana Program Review Panel suggested that the state health commissioner add chronic pain as a qualifying condition.
On May 9, 2017, the New York Senate Health Committee passed Senate Bill 5629, which would consider post-traumatic stress disorder an eligible condition for the state’s medical marijuana program.
DENVER, May 3, 2017 /Weed Wire/ — Making good on a promise from November 2015, Dropleaf, the brand management firm that has obtained the exclusive rights to the Julian Marley’s JuJu Royal brand, has paid $3,800, or 1% of annual sales, to the Weed for Warriors Project.
Marijuana grown by the federal government for research purposes does not have the same quality as the pot from other sources. Until recently, the U.S. federal government had to grow all the marijuana that would be used in scientific research, but researchers have found the government’s pot to be, essentially, irrelevant.
According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.
Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.
On Feb. 8, 2017, the New Mexico Senate Judiciary Committee voted to endorse Senate Bill 8, a bill that would, among many other changes, allow United States military veterans residing in New Mexico to use medical marijuana, regardless of diagnosis.
On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.
PHOENIX, Ariz., Feb. 7, 2017 /Weed Wire/ — On February 6, 2017, the first participant in the first-ever clinical trial of smoked marijuana (cannabis) for post-traumatic stress disorder (PTSD) in U.S. veterans received cannabis at the Scottsdale Research Institute (SRI) in Phoenix, Ariz.
DENVER, Feb. 2, 2017 /Weed Wire/ — The Cannabis Business Alliance (CBA) has released a statement regarding the case against Richard Kirk, who has pled guilty to second-degree murder after confessing to the murder of his wife Kristine Kirk. Much of the news coverage attempted to connect the tragedy to the consumption of a cannabis infused edible.
DENVER, Jan. 30, 2017 /Weed Wire/ — Hoban Law Group is excited to announce that the SB17-17 Post-traumatic Stress Bill, to add Post Traumatic Stress Disorder and Acute Stress Disorder to the list of qualifying conditions for treatment by medical marijuana, has been scheduled for its first committee hearing Monday, January 30th in Senate State Affairs.
For years, Georgia lawmakers have debated the merits of medical marijuana and the discussion will continue this year.
Patient advocates said the swift addition of these patients to the program demonstrates the pent-up demand for the anxiety-reducing and pain-relieving effects of the cannabis plant, as well as the need for the Christie administration to further expand the seven-year-old program.
In South Carolina, Rep. Todd Rutherford has pre-filed a bill that would legalize medical marijuana in the state. Dubbed the Put Patients First Act, the bill would allow qualified patients to possess up to two ounces of medical marijuana as well grow up to six plants.
In Minnesota, medicinal cannabis companies and the state’s health commissioner disagree with the state Veterans Affairs regarding the use of medical marijuana for PTSD. The controversy centers around the commissioner’s decision to include PTSD among the conditions that qualify for medical marijuana, while Veterans Affairs prohibits its use.
On Dec. 7, 2016, District Judge James Reynolds ruled that a drafting error in Montana’s recently passed Initiative 182 cannot delay the medical marijuana initiative’s implementation, immediately striking down a three-patient limit that previously went into effect on Aug. 31, as reported by the Associated Press.
Minnesota residents suffering from post-traumatic stress disorder will soon be able to use medical marijuana to treat their condition.
ST. PAUL, Minn., Dec. 1, 2016 /Weed Wire/ — Minnesota Commissioner of Health Dr. Ed Ehlinger today announced the decision to add post-traumatic stress disorder (PTSD) as a new qualifying condition for the state’s medical cannabis program.
The Minnesota’s Department of Health was expected to announce Thursday whether it would expand the program to people suffering post-traumatic stress disorder, autism, arthritis and others.
On Nov. 22, 2016, Veterans Affairs Canada announced a new reimbursement policy for veterans using medical cannabis. While veterans can now be reimbursed for medical cannabis extracts, the daily reimbursement limit dropped from 10 grams to 3 grams.
A common critique of marijuana use is that the substance is a “gateway drug,” leading users toward a path of hard drug abuse and mental health issues; however, a new clinical review has challenged that assumption.